Cumulative burden of symptomatology in patients with gynecologic malignancies undergoing chemotherapy.
Laura B OswaldSarah L EiselDanielle B TometichCrystal BryantAasha I HooglandBrent J SmallSachin M ApteHye Sook ChonMian M K ShahzadBrian D GonzalezHeather S L JimPublished in: Health psychology : official journal of the Division of Health Psychology, American Psychological Association (2022)
Patients with gynecologic malignancies have high rates of clinically meaningful symptomatology during chemotherapy. Patients may experience a cumulative burden of symptomatology as treatment progresses, which could have therapeutic implications. Early implementation of supportive interventions should be considered to prevent or mitigate cumulative treatment burden. (PsycInfo Database Record (c) 2022 APA, all rights reserved).